Eris Lifesciences (NSE:ERIS) Net Income Including Noncontrolling Interests : ₹3,747 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Eris Lifesciences's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ₹1,020 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,747 Mil.

Eris Lifesciences Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Eris Lifesciences's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Net Income Including Noncontrolling Interests Chart

Eris Lifesciences Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

3,551.35

4,057.89

3,741.60

3,971.20

3,746.70

Eris Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															796.90	894.20	963.50	869.30	1,019.70

Eris Lifesciences Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,747 Mil.

Eris Lifesciences Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » Net Income Including Noncontrolling Interests

Traded in Other Exchanges

540596:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences Headlines

No Headlines